Animal models of human immunodeficiency virus 1, such as feline immunodeficiency virus (FIV), provide the opportunities to dissect the mechanisms of early interactions of the virus with the central nervous system (CNS). The aims of the present study were to evaluate viral loads within CNS, cerebrospinal fluid (CSF), ocular fluid, and the plasma of cats in the first 23 weeks after intravenous inoculation with FIV(GL8). Proviral loads were also determined within peripheral blood mononuclear cells (PBMCs) and brain tissue. In this acute phase of infection, virus entered the brain in the majority of animals. Virus distribution was initially in a random fashion, with more diffuse brain involvement as infection progressed. Virus in the CSF was predictive of brain parenchymal infection. While the peak of virus production in blood coincided with proliferation within brain, more sustained production appeared to continue in brain tissue. In contrast, proviral loads in the brain decreased to undetectable levels in the presence of a strengthening PBMC load. A final observation in this study was that there was no direct correlation between viral loads in regions of brain or ocular tissue and the presence of histopathology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC164807 | PMC |
http://dx.doi.org/10.1128/jvi.77.13.7477-7485.2003 | DOI Listing |
Comp Immunol Microbiol Infect Dis
January 2025
Simbios Biotecnologia, Cachoeirinha, RS, Brazil; Veterinary Medicine Diagnostic Laboratory (LDMV), Institute of Biotechnology (IB), Postgraduate Programs in Animal Health (PPGSA) and Biotechnology (PPGBIO), University of Caxias do Sul (UCS), Caxias do Sul, RS, Brazil. Electronic address:
Feline immunodeficiency virus (FIV) is a retrovirus affecting domestic cats worldwide and causing immunosuppression and reduced quality of life. The prevalence of FIV infection varies according to geographic regions / countries and it is associated with domestic cat health managements (vaccination, neutering, basic health care, etc.).
View Article and Find Full Text PDFAIDS Res Ther
November 2024
Immuology Research Centre, Faculty of Medicine, Mashhad University of Medical Sciences, Azadi Square, Mashhad, Iran.
Background: HTLV-1 is a worldwide distribution retrovirus with 10-20 million infected individuals. ATLL is an Adult T-cell leukaemia lymphoma caused by aggressive T-cell proliferation that is infected by HTLV-1 and is associated with an inferior prognosis. The exact molecular pathogenesis has yet to be fully understood.
View Article and Find Full Text PDFJ Med Virol
October 2024
Department of Ophthalmology & Visual Science, Graduate school of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Human T-cell Lymphotropic Virus Type 1 (HTLV-1) is traditionally linked to severe conditions such as adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy, and HTLV-1 uveitis, with vertical transmission, particularly mother to child thorough breastfeeding, considered the primary route. Despite efforts to reduce vertical transmission through antenatal screening in Japan, horizontal transmission has contributed to the rising prevalence of HTLV-1 in metropolitan areas. This case reports the youngest documented instance of HTLV-1 uveitis resulting from horizontal transmission through sexual contact in an 18-year-old woman.
View Article and Find Full Text PDFRes Vet Sci
November 2024
Division of Transboundary Animal Disease Research, National Institute of Animal Health, National Agriculture and Food Research Organization, Ibaraki, Japan. Electronic address:
This study aimed to develop a screening method to identify Japanese Black (JB) cattle farms at high risk of bovine leukemia virus (BLV) transmission. We introduced a recently established lymphocyte count (LC) cut-off to detect cattle with persistent lymphocytosis (PL). To identify high-risk farms, we examined the relationship between the proportion of cattle with PL and the mean blood proviral loads (PVL) per farm.
View Article and Find Full Text PDFJ Med Virol
August 2024
Laboratoire de Virologie, CHRU Nancy, Vandoeuvre-lès-Nancy, France.
Improving the therapeutic management of HIV-positive persons is a major public health issue and includes better detection of drug resistance mutations (DRMs). The aim of this study was (i) to explore DRMs in HIV-1-positive persons presenting a blood viral load (VL) < 1000 genomes copies (gc)/mL, including the analyze of cerebrospinal fluid (CSF) and HIV-DNA from peripheral blood mononuclear cells using ultradeep sequencing (UDS) and (ii), to evaluate how these DRMs could influence the clinical practices. For each patient (n = 12), including five low-VL patients (i.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!